Fluorescent imaging with substituted cyanine dyes
US-9089603-B2 · Jul 28, 2015 · US
US9470691B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9470691-B2 |
| Application number | US-201414192827-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 27, 2014 |
| Priority date | Sep 23, 2011 |
| Publication date | Oct 18, 2016 |
| Grant date | Oct 18, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention provides novel compounds and methods for hydrocyanines derived from near-infrared cyanine dyes, as reactive oxygen species probes in imaging. In certain embodiments, the present invention provides reduced dyes as substrates for ELISA and Western blots.
Opening claim text (preview).
What is claimed is: 1. A compound having Formula I: wherein each R 1 is an independently selected alkyl group that is additionally substituted with from 0 to 1 R 14 and from 0 to 1 -L-Y—Z; wherein the alkyl is optionally interrupted by at least one heteroatom or an ionic group; R 1a is either hydrogen or deuterium; each R 2a and R 2b is a member independently selected from the group consisting of alkyl, alkenyl, hydroxyalkyl, alkoxyalkyl, aminoalkyl, amidoalkyl, alkylthioalkyl, carboxyalkyl, alkoxycarbonylalkyl, or sulfonatoalkyl; wherein a carbon of the member is additionally substituted with from 0 to 1 -L-Y—Z; each R 3 , R 4 , R 5 , and R 6 is a member independently selected from the group consisting of hydrogen, alkyl, alkenyl, halo, hydroxyl, alkoxy, amino, cyano, carboxyl, alkoxycarbonyl, amido, sulfonato, alkoxyalkyl, carboxyalkyl, alkoxycarbonylalkyl, and sulfonatoalkyl; wherein a carbon of the member is additionally substituted with from 0 to 1 -L-Y—Z; R 8 , R 9 , R 10 , R 11 and R 12 are each a member independently selected from the group consisting of hydrogen, alkyl, alkenyl, halo, alkoxy, sulfonato, hydroxyl, amino, carboxyl, alkoxycarbonyl, cyano, amido, thioacetyl, and -L-Y—Z; wherein at least one member selected from the group consisting of R 8 , R 9 , and R 10 is halo; each R 13 is a member independently selected from the group consisting of hydroxyl, amino, carboxyl, and alkoxycarbonyl; each R 14 is a member independently selected from the group consisting of alkyl, alkenyl, halo, hydroxyl, alkoxy, amino, amido, amidoalkyl, cyano, cyanoalkyl, carboxyl, alkoxycarbonyl, amido, sulfonato, sulfonatoalkyl, thioacetyl, thioacetylalkyl, alkoxycarbonylalkyl, and alkoxyalkyl; wherein the alkyl or alkenyl is additionally substituted with from 0 to 1 R 13 and from 0 to 1 -L-Y—Z; each L is an optional member independently selected from the group consisting of a bond, a C 1 -C 20 alkylene, and a C 1 -C 20 alkenylene; wherein the alkylene or alkenylene is optionally interrupted by at least one heteroatom; each Y is an optional member independently selected from the group consisting of a bond, —O—, —S—, —NH—, —NHC(O)—, —C(O)NH—, —NR 15 —, —NR 15 C(O)—, —C(O)NR 15 —, —N(Z)—, —N(Z)C(O)—, and —C(O)N(Z)—; each Z is independently selected from the group consisting of -L-R 13 and -L-R 16 ; or alternatively, —Y—Z is a member selected from the group consisting of —N(Z 1 ) 2 , —N(Z 1 )C(O)Z 1 , and —C(O)N(Z 1 ) 2 , and the two Z 1 groups are linked to form a cycloalkynyl group; each R 15 is a member independently selected from the group consisting of alkyl and alkoxycarbonylalkyl; wherein the alkyl is optionally interrupted by at least one heteroatom; each R 16 is independently a member selected from the group consisting of activated acyl, acrylamido, optionally substituted alkylsulfonate ester, azido, optionally substituted arylsulfonate ester, optionally substituted amino, aziridino, boronato, cycloalkynyl, cycloalkynylcarbonyl, diazo, formyl, glycidyl, halo, haloacetamidyl, haloalkyl, haloplatinato, halotriazino, hydrazinyl, imido ester, isocyanato, isothiocyanato, maleimidyl, mercapto, phosphoramidityl, a photoactivatable moiety, vinyl sulfonyl, alkynyl, cycloalkynyl, spirocycloalkynyl, a pegylated azido, a pegylated alkynyl, a pegylated cycloalkynyl, a pegylated spirocycloalkynyl, an o-diarylphosphino aryl ester, and an ortho substituted phosphine oxide aryl ester; and wherein said compound has a balanced charge. 2. The compound of claim 1 , wherein each R 16 is independently a member selected from the group consisting of activated acyl, acrylamido, optionally substituted alkylsulfonate ester, azido, optionally substituted arylsulfonate ester, amino, aziridino, boronato, diazo, formyl, glycidyl, halo, haloacetamidyl, haloalkyl, haloplatinato, halotriazino, hydrazinyl, imido ester, isocyanato, isothiocyanato, maleimidyl, mercapto, phosphoramidityl, a photoactivatable moiety, and vinyl sulfonyl. 3. The compound of claim 1 , wherein at least one R 16 is a member independently selected from the group consisting of azido, alkynyl, cycloalkynyl, a pegylated azido, a pegylated alkynyl, a pegylated cycloalkynyl, and an o-diarylphosphino aryl ester. 4. The compound of claim 1 , wherein at least one member selected from the group consisting of R 8 , R 9 , and R 10 is chloro or fluoro. 5. The compound of claim 4 , wherein at least one member selected from the group consisting of R 8 , R 9 , and R 10 is fluoro. 6. The compound of claim 4 , wherein at least one member selected from the group consisting of R 8 , R 9 , and R 10 is chloro. 7. The compound of claim 1 , wherein each R 3 , R 4 , R 5 , and R 6 is a member independently selected from the group consisting of hydrogen, alkyl, alkenyl, halo, alkoxy, cyano, carboxyl, alkoxycarbonyl, amido, sulfonato, alkoxyalkyl, carboxyalkyl, alkoxycarbonylalkyl, and sulfonatoalkyl. 8. The compound of claim 1 , wherein R 1 is (CH 2 ) r SO 3 H or (CH 2 ) r SO 3 − ; and wherein r is an integer from 1 to 20. 9. The compound of claim 8 , wherein r is 2, 3, or 4. 10. The compound of claim 1 , wherein R 2a and R 2b are methyl. 11. The compound of claim 1 , wherein R 8 , R 9 , or R 10 is -L-Y—Z. 12. The compound of claim 1 , having the formula: 13. The compound of claim 1 , wherein the cycloalkynyl group is a member selected from the group consisting of cyclopentynyl, cyclohexynyl, cyclooctynyl, and dibenzocyclooctynyl (DBCO).
for cancer · CPC title
the polymethine chain being part of a carbocyclic ring,(e.g. benzene, naphtalene, cyclohexene, cyclobutenene-quadratic acid) · CPC title
with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring · CPC title
with fluorescent label · CPC title
substituted on the polymethine chain · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.